Market Access Blogs
Drug Pricing – How Pharma Can Ease the Burden
In this POV, market access gurus Mike Motto, Glen Davis, and Peter Weissberg, discuss recent Trump administration action on drug pricing, the likelihood of further action before the 2020 election, and how pharma manufacturers can provide affordable options for more Americans.
The Evolution of Retail Healthcare Models
Major national pharmacy chains have announced new options for patients who would like affordable, one-stop, comprehensive healthcare outside of the traditional care setting, as well as new opportunities for PCPs. Three Intouch market access experts offer considerations and opportunities for pharma marketers to navigate this growing retail healthcare delivery trend.
COVID-19 and Its Impact on Market Access (Payers and Organized Providers)
The COVID-19 pandemic has created new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for HCPs and patients faced with navigating their new access and reimbursement realities.